Diamedica Therapeutics Inc. · NASDAQ:DMAC
TRILL AB reported a 16.90% stake in Diamedica Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 6, 2026
TRILL AB reported a 16.90% stake in Diamedica Therapeutics Inc., 8,825,742 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 16.90%
- Shares
- 8,825,742
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TRILL AB | 16.90% | 8,825,742 |
| Jan Stahlberg | 16.90% | 8,825,742 |
Source
Related
- Diamedica Therapeutics Inc.
- Trill AB
- Diamedica Therapeutics Inc. shareholders
- Schedule 13G/A · Trill AB · Sep 4, 2025
- Schedule 13G/A · Trill AB · Jul 30, 2025
- Form 4 · Pauls Dietrich John · Aug 12, 2026
- Schedule 13G/A · John Fichthorn · Feb 17, 2026
- Schedule 13G/A · Cooperman Leon G · Feb 17, 2026
- Schedule 13G/A · Richard Jacinto II · Nov 7, 2025
- Schedule 13G/A · Cooperman Leon G · Oct 15, 2025